Sartorius Stedim Biotech S.A. (EPA:DIM)
France
· Delayed Price · Currency is EUR 156.80
-2.90 (-1.82%)
Apr 28, 2026, 5:37 PM CET
Sartorius Stedim Biotech Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 15,256 | 20,433 | 18,363 | 22,073 | 27,883 | 44,467 | Upgrade
|
| Market Cap Growth | -18.06% | 11.28% | -16.81% | -20.84% | -37.29% | 65.66% | Upgrade
|
| Enterprise Value | 17,384 | 22,733 | 20,749 | 25,782 | 28,964 | 44,979 | Upgrade
|
| Last Close Price | 156.80 | 209.15 | 187.23 | 237.01 | 297.92 | 473.53 | Upgrade
|
| PE Ratio | 56.84 | 76.93 | 104.87 | 71.14 | 31.83 | 107.31 | Upgrade
|
| Forward PE | 29.57 | 40.98 | 46.49 | 49.64 | 31.48 | 60.28 | Upgrade
|
| PS Ratio | 5.11 | 6.89 | 6.61 | 7.95 | 7.98 | 15.40 | Upgrade
|
| PB Ratio | 3.68 | 4.95 | 4.56 | 8.26 | 11.09 | 25.66 | Upgrade
|
| P/TBV Ratio | - | - | - | - | 46.41 | 163.54 | Upgrade
|
| P/FCF Ratio | 41.43 | 68.34 | 38.63 | 80.91 | 153.46 | 117.67 | Upgrade
|
| P/OCF Ratio | 19.92 | 29.52 | 22.53 | 29.57 | 45.54 | 63.35 | Upgrade
|
| PEG Ratio | 1.29 | 1.86 | 2.29 | 6.24 | 1.67 | 6.53 | Upgrade
|
| EV/Sales Ratio | 5.82 | 7.66 | 7.46 | 9.29 | 8.29 | 15.58 | Upgrade
|
| EV/EBITDA Ratio | 21.37 | 29.22 | 32.97 | 39.20 | 24.20 | 43.61 | Upgrade
|
| EV/EBIT Ratio | 31.96 | 42.25 | 52.40 | 54.93 | 27.47 | 48.88 | Upgrade
|
| EV/FCF Ratio | 47.21 | 76.03 | 43.65 | 94.51 | 159.41 | 119.02 | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.63 | 0.71 | 1.38 | 0.45 | 0.36 | Upgrade
|
| Debt / EBITDA Ratio | 3.21 | 3.23 | 4.38 | 5.39 | 0.93 | 0.60 | Upgrade
|
| Debt / FCF Ratio | 7.10 | 8.69 | 6.04 | 13.50 | 6.25 | 1.66 | Upgrade
|
| Net Debt / Equity Ratio | 0.51 | 0.53 | 0.54 | 1.33 | 0.40 | 0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.65 | 2.78 | 3.47 | 5.41 | 0.84 | 0.38 | Upgrade
|
| Net Debt / FCF Ratio | 5.69 | 7.24 | 4.59 | 13.03 | 5.52 | 1.03 | Upgrade
|
| Asset Turnover | 0.36 | 0.37 | 0.35 | 0.43 | 0.78 | 0.85 | Upgrade
|
| Inventory Turnover | 2.36 | 2.36 | 2.01 | 1.62 | 1.85 | 2.13 | Upgrade
|
| Quick Ratio | 0.51 | 0.47 | 1.05 | 0.49 | 0.53 | 0.59 | Upgrade
|
| Current Ratio | 1.03 | 1.02 | 1.85 | 1.51 | 1.61 | 1.40 | Upgrade
|
| Return on Equity (ROE) | 6.59% | 6.53% | 5.33% | 12.05% | 41.43% | 25.94% | Upgrade
|
| Return on Assets (ROA) | 4.14% | 4.14% | 3.10% | 4.59% | 14.62% | 16.90% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.21% | 6.14% | 5.19% | 7.49% | 29.10% | 28.75% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.30% | 8.20% | 5.40% | 6.90% | 26.20% | 31.60% | Upgrade
|
| Earnings Yield | 1.76% | 1.30% | 0.95% | 1.41% | 3.14% | 0.93% | Upgrade
|
| FCF Yield | 2.41% | 1.46% | 2.59% | 1.24% | 0.65% | 0.85% | Upgrade
|
| Dividend Yield | 0.43% | 0.33% | 0.37% | 0.29% | 0.48% | 0.27% | Upgrade
|
| Payout Ratio | 25.03% | 25.26% | 38.32% | 42.77% | 13.25% | 15.13% | Upgrade
|
| Buyback Yield / Dilution | -0.41% | -0.54% | -5.01% | 0.00% | 0.01% | 0.00% | Upgrade
|
| Total Shareholder Return | 0.02% | -0.21% | -4.64% | 0.29% | 0.50% | 0.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.